After administering your dose, the entire pen should be discarded appropriately (see disposal guidance)
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are approved for treating type 2 diabetes and weight loss
This is where MeAgain's GLP-1 app fits in, tracking doses, estimating clearance windows, and sending reminders to support scheduling of labs and procedures
By maintaining a microdose, patients may be able to achieve the desired effects of the drug while avoiding the dose threshold that triggers severe GI effects, resulting in a better overall experience and adherence to the treatment
DeaneAMChapmanMJFraserRJSummersMJZaknicAVStoreyJPet al
Invading pathogens suppress the growth and decimation of beneficial intestinal bacteria, resulting in an imbalance that renders the host more susceptible to a variety of diseases and conditions, including diarrhea